Valbert Nascimento Cardoso

Valbert Nascimento Cardoso

Auto-generated profile, based on publicly available information

Valbert Nascimento Cardoso

Department of Clinical and Toxicological Analysis, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in EJNMMI Research
Verified
Journal Article
Open access
PDF file
ABAndre Luis Branco de Barros
Andre Luis Branco de Barros
ATAndrew Tsourkas
Andrew Tsourkas
Babak SabouryBabak Saboury
Babak Saboury
VCValbert N Cardoso
Valbert N Cardoso
Abass AlaviAbass Alavi
Abass Alavi
Nanomedicine is emerging as a promising approach for diagnostic applications. Nanoparticles are structures in the nanometer size range, which can present different shapes, compositions, charges, surface modifications, in vitro and in vivo stabilities, and in vivo performances. Nanoparticles can be made of materials of diverse chemical nature, the most common being metals, metal oxides, silicates, polymers, carbon, lipids, and biomolecules. Nanoparticles exist in various morphologies, such as spheres, cylinders, platelets, and tubes. Radiolabeled nanoparticles represent a new class of agent with great potential for clinical applications. This is partly due to their long blood circulation time and plasma stability. In addition, because of the high sensitivity of imaging with radiolabeled compounds, their use has promise of achieving accurate and early diagnosis. This review article focuses on the application of radiolabeled nanoparticles in detecting diseases such as cancer and cardiovascular diseases and also presents an overview about the formulation, stability, and biological properties of the nanoparticles used for diagnostic purposes.

1 May 2010 in Archives of Microbiology
Verified
Journal Article
Closed access
PDF file
SGSimone V. Generoso
Simone V. Generoso
MVMirelle Viana
Mirelle Viana
RSRosana Santos
Rosana Santos
FMFlaviano Martins
Flaviano Martins
JMJosé A. N. Machado
José A. N. Machado
VCValbert N. Cardoso
Valbert N. Cardoso

1 March 2015 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
SSSara Roberta dos Santos
Sara Roberta dos Santos
CCCristiane Rodrigues Corrêa
Cristiane Rodrigues Corrêa
ABAndre Luis Branco de Barros
Andre Luis Branco de Barros
RSRogeria Serakides
Rogeria Serakides
SFSimone Odília Fernandes
Simone Odília Fernandes
AAAntero Silva Ribeiro de Andrade
Antero Silva Ribeiro de Andrade

1 May 2009 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ABAndre Luis Branco de Barros
Andre Luis Branco de Barros
VCValbert Nascimento Cardoso
Valbert Nascimento Cardoso
LMLuciene das Graças Mota
Luciene das Graças Mota
ELElaine Amaral Leite
Elaine Amaral Leite
BOBruno Oliveira
Bruno Oliveira
RARicardo Alves
Ricardo Alves

1 January 2008 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
VCVildete A.S. Carmo
Vildete A.S. Carmo
CFCristiano S. Ferrari
Cristiano S. Ferrari
EREduardo C.O. Reis
Eduardo C.O. Reis
GRGilson A. Ramaldes
Gilson A. Ramaldes
MPMaira A. Pereira
Maira A. Pereira
VCValbert N. Cardoso
Valbert N. Cardoso
Purpose To investigate the biodistribution and the ability of stealth pH-sensitive liposomes radiolabelled with 99mTc to identify inflammatory regions in a rat focal inflammation model. Methods Preformed glutathione-containing stealth pH-sensitive liposomes were labelled with 99mTc-hexamethylpropylene amine oxime (99mTc-HMPAO). The 99mTc-HMPAO radiolabelled stealth pH-sensitive liposomes (99mTc-SpHL) were administered intravenously in Wistar male rats with inflammation induced by injection subplantar of carrageenan in the right foot. At pre-established time intervals the animals were anaesthetized and tissues were removed and analysed for 99mTc content using an automatic scintillation apparatus. Scintigraphic imaging was also performed after 2, 4 and 8 h of intravenous injection of 99mTc-SpHL. Results The 99mTc-SpHL was significantly taken up by the spleen (19.21±2.98%ID/g at 30 min post-injection). Low radioactivity levels were found in the liver, lungs, and kidney. Moreover, the 99mTc-SpHL uptake was significantly higher in the inflamed foot when compared to the respective control (0.386±0.059 and 0.215±0.018%ID/g at 2 h post-injection, respectively). As early as 30 min after administration of 99mTc-SpHL, the focus of inflammation could be visualized scintigraphically. The value of the inflammatory and non-inflammatory site radioactivity counting ratio was greater than 5. Conclusion This result indicates that the 99mTc-SpHL presents a high tropism for inflammatory regions and may be useful as a radiopharmaceutical to identify these foci.

1 August 2017 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
RARaquel Silva Araújo
Raquel Silva Araújo
ASAna Letícia Malheiros Silveira
Ana Letícia Malheiros Silveira
ÉSÉricka Lorenna de Sales e Souza
Éricka Lorenna de Sales e Souza
RFRachel Horta Freire
Rachel Horta Freire
CSCristina Maria de Souza
Cristina Maria de Souza
VCValbert Nascimento Cardoso
Valbert Nascimento Cardoso